Sarah J Beesley1,2, Jeff Sorensen1, Allan J Walkey3, Joseph E Tonna4,5, Michael J Lanspa1, Ellie Hirshberg1,2,6, Colin K Grissom1,2, Benjamin D Horne7,8, Rebecca Burk1,2, Theodore P Abraham9, Robert Paine2, Samuel M Brown1,2. 1. Division of Pulmonary, Department of Medicine, Intermountain Medical Center, Salt Lake City, UT. 2. Division of Pulmonary, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT. 3. Division of Pulmonary, Department of Medicine, Boston University, Boston, MA. 4. Division of Cardiothoracic Surgery, University of Utah School of Medicine, Salt Lake City, UT. 5. Division of Emergency Medicine, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT. 6. Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT. 7. Intermountain Medical Center Heart Institute, Intermountain Healthcare, Salt Lake City, UT. 8. Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA. 9. Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, CA.
Abstract
OBJECTIVES: Septic cardiomyopathy develops frequently in patients with sepsis and likely increases short-term mortality. However, whether septic cardiomyopathy is associated with long-term outcomes after sepsis is unknown. We investigated whether septic patients with septic cardiomyopathy have worse long-term outcomes than septic patients without septic cardiomyopathy. DESIGN: Retrospective cohort study. SETTING: Adult ICU. PATIENTS: Adult ICU patients with sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Left ventricular global longitudinal systolic strain was our primary measure of septic cardiomyopathy. We employed a suite of multivariable survival analyses to explore linear and nonlinear associations between left ventricular global longitudinal systolic strain and major adverse cardiovascular events, which included death, stroke, and myocardial infarction. Our primary outcome was major adverse cardiovascular event through 24 months after ICU discharge. Among 290 study patients, median left ventricular global longitudinal systolic strain was -16.8% (interquartile range, -20.4% to -12.6%), and 38.3% of patients (n = 111) experienced a major adverse cardiovascular event within 24 months after discharge. On our primary, linear analysis, there was a trend (p = 0.08) toward association between left ventricular global longitudinal systolic strain and major adverse cardiovascular event (odds ratio, 1.03; CI, < 1 to 1.07). On our nonlinear analysis, the association was highly significant (p < 0.001) with both high and low left ventricular global longitudinal systolic strain associated with major adverse cardiovascular event among patients with pre-existing cardiac disease. This association was pronounced among patients who were younger (age < 65 yr) and had Charlson Comorbidity Index greater than 5. CONCLUSIONS: Among patients with sepsis and pre-existing cardiac disease who survived to ICU discharge, left ventricular global longitudinal systolic strain demonstrated a U-shaped association with cardiovascular outcomes through 24 months. The relationship was especially strong among younger patients with more comorbidities. These observations are likely of use to design of future trials.
OBJECTIVES: Septic cardiomyopathy develops frequently in patients with sepsis and likely increases short-term mortality. However, whether septic cardiomyopathy is associated with long-term outcomes after sepsis is unknown. We investigated whether septic patients with septic cardiomyopathy have worse long-term outcomes than septic patients without septic cardiomyopathy. DESIGN: Retrospective cohort study. SETTING: Adult ICU. PATIENTS: Adult ICU patients with sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Left ventricular global longitudinal systolic strain was our primary measure of septic cardiomyopathy. We employed a suite of multivariable survival analyses to explore linear and nonlinear associations between left ventricular global longitudinal systolic strain and major adverse cardiovascular events, which included death, stroke, and myocardial infarction. Our primary outcome was major adverse cardiovascular event through 24 months after ICU discharge. Among 290 study patients, median left ventricular global longitudinal systolic strain was -16.8% (interquartile range, -20.4% to -12.6%), and 38.3% of patients (n = 111) experienced a major adverse cardiovascular event within 24 months after discharge. On our primary, linear analysis, there was a trend (p = 0.08) toward association between left ventricular global longitudinal systolic strain and major adverse cardiovascular event (odds ratio, 1.03; CI, < 1 to 1.07). On our nonlinear analysis, the association was highly significant (p < 0.001) with both high and low left ventricular global longitudinal systolic strain associated with major adverse cardiovascular event among patients with pre-existing cardiac disease. This association was pronounced among patients who were younger (age < 65 yr) and had Charlson Comorbidity Index greater than 5. CONCLUSIONS: Among patients with sepsis and pre-existing cardiac disease who survived to ICU discharge, left ventricular global longitudinal systolic strain demonstrated a U-shaped association with cardiovascular outcomes through 24 months. The relationship was especially strong among younger patients with more comorbidities. These observations are likely of use to design of future trials.
Authors: Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Sachin Yende; Walter Linde-Zwirble; Florian Mayr; Lisa A Weissfeld; Steven Reis; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2014-05-01 Impact factor: 21.405
Authors: Vicente F Corrales-Medina; Karina N Alvarez; Lisa A Weissfeld; Derek C Angus; Julio A Chirinos; Chung-Chou H Chang; Anne Newman; Laura Loehr; Aaron R Folsom; Mitchell S Elkind; Mary F Lyles; Richard A Kronmal; Sachin Yende Journal: JAMA Date: 2015-01-20 Impact factor: 56.272
Authors: Liam Smeeth; Sara L Thomas; Andrew J Hall; Richard Hubbard; Paddy Farrington; Patrick Vallance Journal: N Engl J Med Date: 2004-12-16 Impact factor: 91.245
Authors: Rathika Krishnasamy; Nicole M Isbel; Carmel M Hawley; Elaine M Pascoe; Matthew Burrage; Rodel Leano; Brian A Haluska; Thomas H Marwick; Tony Stanton Journal: PLoS One Date: 2015-05-15 Impact factor: 3.240
Authors: Michael J Lanspa; Sajid Shahul; Andrew Hersh; Emily L Wilson; Troy D Olsen; Eliotte L Hirshberg; Colin K Grissom; Samuel M Brown Journal: Ann Intensive Care Date: 2017-02-17 Impact factor: 6.925
Authors: F Sanfilippo; C Corredor; N Fletcher; L Tritapepe; F L Lorini; A Arcadipane; A Vieillard-Baron; M Cecconi Journal: Crit Care Date: 2018-08-04 Impact factor: 9.097
Authors: Leah B Kosyakovsky; Federico Angriman; Emma Katz; Neill K Adhikari; Lucas C Godoy; John C Marshall; Bruno L Ferreyro; Douglas S Lee; Robert S Rosenson; Naveed Sattar; Subodh Verma; Augustin Toma; Marina Englesakis; Barry Burstein; Michael E Farkouh; Margaret Herridge; Dennis T Ko; Damon C Scales; Michael E Detsky; Lior Bibas; Patrick R Lawler Journal: Intensive Care Med Date: 2021-08-09 Impact factor: 17.440